Advisors Preferred, LLC Emergent Bio Solutions Inc. Transaction History

Advisors Preferred, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$56.61 - $80.46 $120,579 - $171,379	-2,130 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$86.23 - $125.19 $496,253 - $720,468	-5,755 Reduced 72.99%	2,130 $171,000
Q4 2020 Feb 03, 2021	BUY	$79.17 - $111.47 $175,678 - $247,351	2,219 Added 39.16%	7,885 $734,000
Q3 2020 Nov 12, 2020	BUY	$81.91 - $134.94 $464,102 - $764,570	5,666 New	5,666 $585,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Advisors Preferred, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisors Preferred, LLC with notifications on news.